Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertrand Arnulf

Showing results (31-40 of 152) with videos related to

Pageof 16
Sort By:
Haematologica|February 18, 2021
Light chain proteinuria revealing mu-heavy chain disease: an atypical presentation of Waldenström macroglobulinemia in two casesHélène Vergneault, Djaouida Bengoufa, Aline Frazier-Mironer, et al.
British Journal of Haematology|February 10, 2022
Multiple myeloma occurring in a case of Niemann-Pick disease Type B: A pathophysiological link?Elodie Portier, Alexis Talbot, Yann Nguyen, et al.
EMBO Molecular Medicine|January 11, 2022
The Sec61 translocon is a therapeutic vulnerability in multiple myelomaAntoine Domenger, Caroline Choisy, Ludivine Baron, et al.
Medicine|July 2, 2016
Loss of tubular creatinine secretion as the only sign of tubular proximal cell dysfunction in light chain proximal tubulopathy: A case reportThomas Stehlé, Marguerite Vignon, Martin Flamant, et al.
British Journal of Haematology|February 4, 2020
Carfilzomib, venetoclax and dexamethasone for relapsed/refractory multiple myelomaClémentine Boccon-Gibod, Alexis Talbot, Fabien Le Bras, et al.
Blood|November 1, 2003
A neutralizing monoclonal antibody (mAb A24) directed against the transferrin receptor induces apoptosis of tumor T lymphocytes from ATL patientsIvan C Moura, Yves Lepelletier, Bertrand Arnulf, et al.
Gastroenterology|February 28, 2007
Inhibition of TGF-beta signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac diseaseMélika Benahmed, Bertrand Meresse, Bertrand Arnulf, et al.
Haematologica|June 13, 2012
Updated survival analysis of a randomized phase III study of subcutaneous versus intravenous bortezomib in patients with relapsed multiple myelomaBertrand Arnulf, Halyna Pylypenko, Sebastian Grosicki, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 21, 2025
Cardiac Phenotype and Clinical Outcomes in Randall Disease versus Light-Chain AmyloidosisMartin Nicol, Camille Cohen, Alexis Talbot, et al.
The American Journal of Pathology|March 29, 2005
Analysis of interleukin-27 (EBI3/p28) expression in Epstein-Barr virus- and human T-cell leukemia virus type 1-associated lymphomas: heterogeneous expression of EBI3 subunit by tumoral cellsFrédérique Larousserie, Emilie Bardel, Stefan Pflanz, et al.
Pageof 16

Showing results (31-40 of 152) with videos related to

Sort By:
Pageof 16
Haematologica|February 18, 2021
Light chain proteinuria revealing mu-heavy chain disease: an atypical presentation of Waldenström macroglobulinemia in two casesHélène Vergneault, Djaouida Bengoufa, Aline Frazier-Mironer, et al.
British Journal of Haematology|February 10, 2022
Multiple myeloma occurring in a case of Niemann-Pick disease Type B: A pathophysiological link?Elodie Portier, Alexis Talbot, Yann Nguyen, et al.
EMBO Molecular Medicine|January 11, 2022
The Sec61 translocon is a therapeutic vulnerability in multiple myelomaAntoine Domenger, Caroline Choisy, Ludivine Baron, et al.
Medicine|July 2, 2016
Loss of tubular creatinine secretion as the only sign of tubular proximal cell dysfunction in light chain proximal tubulopathy: A case reportThomas Stehlé, Marguerite Vignon, Martin Flamant, et al.
British Journal of Haematology|February 4, 2020
Carfilzomib, venetoclax and dexamethasone for relapsed/refractory multiple myelomaClémentine Boccon-Gibod, Alexis Talbot, Fabien Le Bras, et al.
Blood|November 1, 2003
A neutralizing monoclonal antibody (mAb A24) directed against the transferrin receptor induces apoptosis of tumor T lymphocytes from ATL patientsIvan C Moura, Yves Lepelletier, Bertrand Arnulf, et al.
Gastroenterology|February 28, 2007
Inhibition of TGF-beta signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac diseaseMélika Benahmed, Bertrand Meresse, Bertrand Arnulf, et al.
Haematologica|June 13, 2012
Updated survival analysis of a randomized phase III study of subcutaneous versus intravenous bortezomib in patients with relapsed multiple myelomaBertrand Arnulf, Halyna Pylypenko, Sebastian Grosicki, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 21, 2025
Cardiac Phenotype and Clinical Outcomes in Randall Disease versus Light-Chain AmyloidosisMartin Nicol, Camille Cohen, Alexis Talbot, et al.
The American Journal of Pathology|March 29, 2005
Analysis of interleukin-27 (EBI3/p28) expression in Epstein-Barr virus- and human T-cell leukemia virus type 1-associated lymphomas: heterogeneous expression of EBI3 subunit by tumoral cellsFrédérique Larousserie, Emilie Bardel, Stefan Pflanz, et al.
Pageof 16